Report Detail

Request for Sample of this report

Pharma & Healthcare Global Therapeutic Antibodies Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4566999
    • |
  • 24 November, 2023
    • |
  • Global
    • |
  • 128 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Therapeutic Antibodies Drug market size was valued at USD 180490 million in 2022 and is forecast to a readjusted size of USD 363690 million by 2029 with a CAGR of 10.5% during review period.
Therapeutic antibodies are drugs that use antibodies, one of the main players in our immune system inherent in our body. By making use of the specificity by which each antibody recognizes only one antigen, pinpointed attacks on specific antigens are possible.
The Therapeutic Antibodies Drug Market is driven by the remarkable potential of therapeutic antibodies to treat a diverse array of diseases, from cancer and autoimmune disorders to infectious diseases. Monoclonal antibodies have gained prominence as highly targeted and effective therapeutic agents that can modulate the immune system, neutralize pathogens, and inhibit disease-associated proteins. As precision medicine and biopharmaceutical innovations continue to advance, the demand for therapeutic antibodies grows. Innovations in antibody design, engineering, and manufacturing technologies further contribute to market expansion. Nevertheless, a significant challenge for this market is the need to address high production costs, optimize therapeutic antibody development processes, and navigate complex regulatory pathways while ensuring accessibility and affordability for patients. Overcoming manufacturing complexities, managing research and development costs, and addressing regulatory standards are ongoing challenges. Additionally, the market faces competition from small molecules and other biologic therapies, necessitating continuous research and development efforts to unlock the full therapeutic potential of therapeutic antibodies. Striking a balance between providing safe, effective, and accessible therapeutic antibody drugs while addressing scientific and regulatory challenges is essential for the continued growth of the Therapeutic Antibodies Drug Market.
The Global Info Research report includes an overview of the development of the Therapeutic Antibodies Drug industry chain, the market status of Immune Diseases (Monoclonal Antibodies, Bi-Specific Antibodies Therapy), Cancer (Monoclonal Antibodies, Bi-Specific Antibodies Therapy), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Therapeutic Antibodies Drug.
Regionally, the report analyzes the Therapeutic Antibodies Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Therapeutic Antibodies Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Therapeutic Antibodies Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Therapeutic Antibodies Drug industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Monoclonal Antibodies, Bi-Specific Antibodies Therapy).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Therapeutic Antibodies Drug market.
Regional Analysis: The report involves examining the Therapeutic Antibodies Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Therapeutic Antibodies Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Therapeutic Antibodies Drug:
Company Analysis: Report covers individual Therapeutic Antibodies Drug players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Therapeutic Antibodies Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Immune Diseases, Cancer).
Technology Analysis: Report covers specific technologies relevant to Therapeutic Antibodies Drug. It assesses the current state, advancements, and potential future developments in Therapeutic Antibodies Drug areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Therapeutic Antibodies Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Therapeutic Antibodies Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Monoclonal Antibodies
Bi-Specific Antibodies Therapy
Antibody-drug Conjugates
Other
Market segment by Application
Immune Diseases
Cancer
Other
Market segment by players, this report covers
AbbVie
Johnson & Johnson
Novartis
Gilead Sciences
Roche
Bristol-Myers Squibb
Amgen
AstraZeneca
Merck & Co
Takeda
Merck KGaA
Seagen
Eli Lilly
Ono Pharmaceutical
Pfizer
Regeneron
Innovent
Hengrui Medicine
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Therapeutic Antibodies Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Therapeutic Antibodies Drug, with revenue, gross margin and global market share of Therapeutic Antibodies Drug from 2018 to 2023.
Chapter 3, the Therapeutic Antibodies Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Therapeutic Antibodies Drug market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Therapeutic Antibodies Drug.
Chapter 13, to describe Therapeutic Antibodies Drug research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Therapeutic Antibodies Drug
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Therapeutic Antibodies Drug by Type
    • 1.3.1 Overview: Global Therapeutic Antibodies Drug Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Therapeutic Antibodies Drug Consumption Value Market Share by Type in 2022
    • 1.3.3 Monoclonal Antibodies
    • 1.3.4 Bi-Specific Antibodies Therapy
    • 1.3.5 Antibody-drug Conjugates
    • 1.3.6 Other
  • 1.4 Global Therapeutic Antibodies Drug Market by Application
    • 1.4.1 Overview: Global Therapeutic Antibodies Drug Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Immune Diseases
    • 1.4.3 Cancer
    • 1.4.4 Other
  • 1.5 Global Therapeutic Antibodies Drug Market Size & Forecast
  • 1.6 Global Therapeutic Antibodies Drug Market Size and Forecast by Region
    • 1.6.1 Global Therapeutic Antibodies Drug Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Therapeutic Antibodies Drug Market Size by Region, (2018-2029)
    • 1.6.3 North America Therapeutic Antibodies Drug Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Therapeutic Antibodies Drug Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Therapeutic Antibodies Drug Market Size and Prospect (2018-2029)
    • 1.6.6 South America Therapeutic Antibodies Drug Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Therapeutic Antibodies Drug Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 AbbVie
    • 2.1.1 AbbVie Details
    • 2.1.2 AbbVie Major Business
    • 2.1.3 AbbVie Therapeutic Antibodies Drug Product and Solutions
    • 2.1.4 AbbVie Therapeutic Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 AbbVie Recent Developments and Future Plans
  • 2.2 Johnson & Johnson
    • 2.2.1 Johnson & Johnson Details
    • 2.2.2 Johnson & Johnson Major Business
    • 2.2.3 Johnson & Johnson Therapeutic Antibodies Drug Product and Solutions
    • 2.2.4 Johnson & Johnson Therapeutic Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Johnson & Johnson Recent Developments and Future Plans
  • 2.3 Novartis
    • 2.3.1 Novartis Details
    • 2.3.2 Novartis Major Business
    • 2.3.3 Novartis Therapeutic Antibodies Drug Product and Solutions
    • 2.3.4 Novartis Therapeutic Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Novartis Recent Developments and Future Plans
  • 2.4 Gilead Sciences
    • 2.4.1 Gilead Sciences Details
    • 2.4.2 Gilead Sciences Major Business
    • 2.4.3 Gilead Sciences Therapeutic Antibodies Drug Product and Solutions
    • 2.4.4 Gilead Sciences Therapeutic Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Gilead Sciences Recent Developments and Future Plans
  • 2.5 Roche
    • 2.5.1 Roche Details
    • 2.5.2 Roche Major Business
    • 2.5.3 Roche Therapeutic Antibodies Drug Product and Solutions
    • 2.5.4 Roche Therapeutic Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Roche Recent Developments and Future Plans
  • 2.6 Bristol-Myers Squibb
    • 2.6.1 Bristol-Myers Squibb Details
    • 2.6.2 Bristol-Myers Squibb Major Business
    • 2.6.3 Bristol-Myers Squibb Therapeutic Antibodies Drug Product and Solutions
    • 2.6.4 Bristol-Myers Squibb Therapeutic Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Bristol-Myers Squibb Recent Developments and Future Plans
  • 2.7 Amgen
    • 2.7.1 Amgen Details
    • 2.7.2 Amgen Major Business
    • 2.7.3 Amgen Therapeutic Antibodies Drug Product and Solutions
    • 2.7.4 Amgen Therapeutic Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Amgen Recent Developments and Future Plans
  • 2.8 AstraZeneca
    • 2.8.1 AstraZeneca Details
    • 2.8.2 AstraZeneca Major Business
    • 2.8.3 AstraZeneca Therapeutic Antibodies Drug Product and Solutions
    • 2.8.4 AstraZeneca Therapeutic Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 AstraZeneca Recent Developments and Future Plans
  • 2.9 Merck & Co
    • 2.9.1 Merck & Co Details
    • 2.9.2 Merck & Co Major Business
    • 2.9.3 Merck & Co Therapeutic Antibodies Drug Product and Solutions
    • 2.9.4 Merck & Co Therapeutic Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Merck & Co Recent Developments and Future Plans
  • 2.10 Takeda
    • 2.10.1 Takeda Details
    • 2.10.2 Takeda Major Business
    • 2.10.3 Takeda Therapeutic Antibodies Drug Product and Solutions
    • 2.10.4 Takeda Therapeutic Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Takeda Recent Developments and Future Plans
  • 2.11 Merck KGaA
    • 2.11.1 Merck KGaA Details
    • 2.11.2 Merck KGaA Major Business
    • 2.11.3 Merck KGaA Therapeutic Antibodies Drug Product and Solutions
    • 2.11.4 Merck KGaA Therapeutic Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Merck KGaA Recent Developments and Future Plans
  • 2.12 Seagen
    • 2.12.1 Seagen Details
    • 2.12.2 Seagen Major Business
    • 2.12.3 Seagen Therapeutic Antibodies Drug Product and Solutions
    • 2.12.4 Seagen Therapeutic Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Seagen Recent Developments and Future Plans
  • 2.13 Eli Lilly
    • 2.13.1 Eli Lilly Details
    • 2.13.2 Eli Lilly Major Business
    • 2.13.3 Eli Lilly Therapeutic Antibodies Drug Product and Solutions
    • 2.13.4 Eli Lilly Therapeutic Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Eli Lilly Recent Developments and Future Plans
  • 2.14 Ono Pharmaceutical
    • 2.14.1 Ono Pharmaceutical Details
    • 2.14.2 Ono Pharmaceutical Major Business
    • 2.14.3 Ono Pharmaceutical Therapeutic Antibodies Drug Product and Solutions
    • 2.14.4 Ono Pharmaceutical Therapeutic Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Ono Pharmaceutical Recent Developments and Future Plans
  • 2.15 Pfizer
    • 2.15.1 Pfizer Details
    • 2.15.2 Pfizer Major Business
    • 2.15.3 Pfizer Therapeutic Antibodies Drug Product and Solutions
    • 2.15.4 Pfizer Therapeutic Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Pfizer Recent Developments and Future Plans
  • 2.16 Regeneron
    • 2.16.1 Regeneron Details
    • 2.16.2 Regeneron Major Business
    • 2.16.3 Regeneron Therapeutic Antibodies Drug Product and Solutions
    • 2.16.4 Regeneron Therapeutic Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 Regeneron Recent Developments and Future Plans
  • 2.17 Innovent
    • 2.17.1 Innovent Details
    • 2.17.2 Innovent Major Business
    • 2.17.3 Innovent Therapeutic Antibodies Drug Product and Solutions
    • 2.17.4 Innovent Therapeutic Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.17.5 Innovent Recent Developments and Future Plans
  • 2.18 Hengrui Medicine
    • 2.18.1 Hengrui Medicine Details
    • 2.18.2 Hengrui Medicine Major Business
    • 2.18.3 Hengrui Medicine Therapeutic Antibodies Drug Product and Solutions
    • 2.18.4 Hengrui Medicine Therapeutic Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.18.5 Hengrui Medicine Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Therapeutic Antibodies Drug Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Therapeutic Antibodies Drug by Company Revenue
    • 3.2.2 Top 3 Therapeutic Antibodies Drug Players Market Share in 2022
    • 3.2.3 Top 6 Therapeutic Antibodies Drug Players Market Share in 2022
  • 3.3 Therapeutic Antibodies Drug Market: Overall Company Footprint Analysis
    • 3.3.1 Therapeutic Antibodies Drug Market: Region Footprint
    • 3.3.2 Therapeutic Antibodies Drug Market: Company Product Type Footprint
    • 3.3.3 Therapeutic Antibodies Drug Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Therapeutic Antibodies Drug Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Therapeutic Antibodies Drug Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Therapeutic Antibodies Drug Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Therapeutic Antibodies Drug Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Therapeutic Antibodies Drug Consumption Value by Type (2018-2029)
  • 6.2 North America Therapeutic Antibodies Drug Consumption Value by Application (2018-2029)
  • 6.3 North America Therapeutic Antibodies Drug Market Size by Country
    • 6.3.1 North America Therapeutic Antibodies Drug Consumption Value by Country (2018-2029)
    • 6.3.2 United States Therapeutic Antibodies Drug Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Therapeutic Antibodies Drug Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Therapeutic Antibodies Drug Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Therapeutic Antibodies Drug Consumption Value by Type (2018-2029)
  • 7.2 Europe Therapeutic Antibodies Drug Consumption Value by Application (2018-2029)
  • 7.3 Europe Therapeutic Antibodies Drug Market Size by Country
    • 7.3.1 Europe Therapeutic Antibodies Drug Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Therapeutic Antibodies Drug Market Size and Forecast (2018-2029)
    • 7.3.3 France Therapeutic Antibodies Drug Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Therapeutic Antibodies Drug Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Therapeutic Antibodies Drug Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Therapeutic Antibodies Drug Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Therapeutic Antibodies Drug Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Therapeutic Antibodies Drug Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Therapeutic Antibodies Drug Market Size by Region
    • 8.3.1 Asia-Pacific Therapeutic Antibodies Drug Consumption Value by Region (2018-2029)
    • 8.3.2 China Therapeutic Antibodies Drug Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Therapeutic Antibodies Drug Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Therapeutic Antibodies Drug Market Size and Forecast (2018-2029)
    • 8.3.5 India Therapeutic Antibodies Drug Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Therapeutic Antibodies Drug Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Therapeutic Antibodies Drug Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Therapeutic Antibodies Drug Consumption Value by Type (2018-2029)
  • 9.2 South America Therapeutic Antibodies Drug Consumption Value by Application (2018-2029)
  • 9.3 South America Therapeutic Antibodies Drug Market Size by Country
    • 9.3.1 South America Therapeutic Antibodies Drug Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Therapeutic Antibodies Drug Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Therapeutic Antibodies Drug Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Therapeutic Antibodies Drug Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Therapeutic Antibodies Drug Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Therapeutic Antibodies Drug Market Size by Country
    • 10.3.1 Middle East & Africa Therapeutic Antibodies Drug Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Therapeutic Antibodies Drug Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Therapeutic Antibodies Drug Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Therapeutic Antibodies Drug Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Therapeutic Antibodies Drug Market Drivers
  • 11.2 Therapeutic Antibodies Drug Market Restraints
  • 11.3 Therapeutic Antibodies Drug Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Therapeutic Antibodies Drug Industry Chain
  • 12.2 Therapeutic Antibodies Drug Upstream Analysis
  • 12.3 Therapeutic Antibodies Drug Midstream Analysis
  • 12.4 Therapeutic Antibodies Drug Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Therapeutic Antibodies Drug. Industry analysis & Market Report on Therapeutic Antibodies Drug is a syndicated market report, published as Global Therapeutic Antibodies Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Therapeutic Antibodies Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,780.52
    		4,170.78
    		5,561.04
    		3,229.44
    		4,844.16
    		6,458.88
    		542,392.80
    		813,589.20
    		1,084,785.60
    		290,823.60
    		436,235.40
    		581,647.20
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo